Most urologists considered regular PSA monitoring important in men with LUTS/BPE treated with 5ARIs, primarily for the purpose of identifying prostate cancer, and around 95% of urologists reported monitoring PSA at regular intervals. This evidence concerns the gene KLK3 and prostate carcinoma.